CRB also co-sponsors the following multipurpose prevention technologies funding opportunities:
- PAR-23-180: Next Generation Multipurpose Prevention Technologies (R01 Clinical Trial Optional)
- PAR-21-298: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed)
- PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed)